KalVista, Carbylan Therapeutics deal

Carbylan will merge with KalVista in a stock deal, with KalVista expected to

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE